Results 161 to 170 of about 246,153 (308)

Features of functional and dysfunctional CD8+ T cells to guide HIV vaccine development. [PDF]

Curr Opin HIV AIDS, 2023
Bhattacharyya S, Crain CR, Goldberg B, Gaiha GD.   +3 more
europepmc   +1 more source

Prediction of HIV vaccine [PDF]

Nature, 1987
B, Robson, R V, Fishleigh, C A, Morrison
openaire   +2 more sources

The strategic use and potential demand for an HIV vaccine in Southern Africa [PDF]

HIV prevalence in Southern Africa is the highest in the world and the impact of HIV/AIDS in the region are devastating at all levels of society, including the wider economy. Government response has lagged behind the pace of the epidemic, but programs are
Desmond, Christopher, Greener, Robert
core  

Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome

Pediatric Dermatology, EarlyView.
ABSTRACT Chediak–Higashi syndrome (CHS) is a rare autosomal recessive primary immunodeficiency characterized by partial oculocutaneous albinism, neurologic involvement, and a predisposition to severe infections. Patients are particularly susceptible to developing hemophagocytic lymphohistiocytosis (HLH), which significantly worsens prognosis. We report
Albane Badet, Clément Pruvot, Zoé Manssens, Wadih Abou‐Chahla, Sébastien Buche   +4 more
wiley   +1 more source

Status of HIV vaccine development: progress and promise. [PDF]

J Int AIDS Soc
Haynes BF, Saunders KO, Hahn BH, Wiehe K, Baden LR, Shaw GM.   +5 more
europepmc   +1 more source

When Regulation Travels: Distrust and Disrespect

Regulation &Governance, EarlyView.
ABSTRACT Endeavoring to avoid the pitfalls of being too trusting of regulated entities' compliance claims, regulators sometimes create regulatory systems with elaborate requirements for verification. But as these accountability and verification regimes attempt to circumvent one set of problems, they may inadvertently create others.
Carol A. Heimer
wiley   +1 more source

In danger: HIV vaccine research and development in Europe. [PDF]

PLOS Glob Public Health
Tatoud R, Lévy Y, Le Grand R, Alcami J, Barbareschi G, Brander C, Cara A, Combadière B, Dabis F, Fidler S, Hanke T, Herrera C, Karlsson Hedestam GB, Kuipers H, McCormack S, Moog C, Pantaleo G, Richert L, Sanders RW, Shattock R, Streeck H, Thiebaut R, Trkola A, Üeberla K, Van Gills MJ, Wagner R, Weissenhorn W, Yazdanpanah Y, Scarlatti G, Lelièvre JD.   +29 more
europepmc   +1 more source

Accelerating HIV vaccine development through meaningful engagement of local scientists and communities. [PDF]

Curr Opin HIV AIDS, 2023
Chinyenze K, Nduati E, Muturi-Kioi V.
europepmc   +1 more source

HIV vaccine AIDSVAX

Drugs in R & D, 1999
openaire   +2 more sources

Pan‐European Fragile Populations Cohort for COVID‐19: What Worked, What Didn't, and Lessons Learned

Transplant Infectious Disease, EarlyView.
ABSTRACT The COVID‐19 pandemic exposed the vulnerability of immunocompromised hosts and the scarcity of evidence guiding their management. Within the European Horizon 2020 ORCHESTRA project, a multinational consortium connected existing and new cohorts to harmonize data, laboratory methods, and clinical expertise across fragile populations. The fragile
Beatrice Tazza, Cecilia Bonazzetti, Natascia Caroccia, Michela Di Chiara, Lorenzo Maria Canziani, Anna Maria Azzini, Zaira R. Palacios Baena, Paula Olivares‐Navarro, Jesús Rodríguez‐Baño, Evelina Tacconelli, Pierluigi Viale, Maddalena Giannella   +11 more
wiley   +1 more source